Clinical Trial Award – HT942524MSRPCTA
- Funding Level 1 – up to USD$2M over 3 years – early phase, proof of principle clinical trials to demonstrate feasibility or inform design of more advanced trials
- Funding Level 2 – up to USD$4M over 4 years – larger-scale clinical trials at phase 1 or 2 that seek to show preliminary evidence of safety or efficacy
- pre-proposals due 10 June 2024
- cannot be used for pre-clinical studies
- scientific rational and preliminary data required
- must address at least one of focus areas: Promoting Repair,
Neuroprotection, and Remyelination in MS; or Treatment of MS Symptoms - Document – Funding Announcement: HT942524MSRPCTA_GG
Early Investigator Research Award – HT942524MSRPEIRA
- up to USD$320,000 over 2 years
- letters of intent due 24 July 2024
- must have 1 – 4 years continuous postdoc research experience
- must commit at least 50% of effort to project
- must have a designated mentor who is an experienced MS researcher
- clinical trials not allowed
- must address at least one focus area: Central Nervous System Repair, Protection, and Regenerative Potential in MS; or Correlates of Disease Activity and Progression in MS; or Biology and Measurements of MS Symptoms; or Mechanisms Contributing to or Associated with MS Etiology, Prodrome, Onset, and Disease
Course - Document – Funding Announcement: HT942524MSRPEIRA_GG
Exploration – Hypothesis Development Award – HT942524MSRPEHDA
- up to USD$250,000 over 2 years
- pre-proposals due 10 June 2024
- supports initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts
- New Investigator Option available
- preliminary data not required
- clinical trials not allowed
- must address at least one focus area: Central Nervous System Repair, Protection, and Regenerative Potential in MS; or Correlates of Disease Activity and Progression in MS; or Biology and Measurements of MS Symptoms; or Mechanisms Contributing to or Associated with MS Etiology, Prodrome, Onset, and Disease
Course - Document – Funding Announcement: HT942524MSRPEHDA_GG
Investigator-Initiated Research Award – HT942524MSRPIIRA
- up to USD$1M over 3 years
- pre-proposals due 10 June 2024
- supports highly rigorous, high-impact research with the potential to make an important contribution to MS research and/or patient care
- New Investigator Option available
- preliminary data not required
- clinical trials not allowed
- must address at least one focus area: Central Nervous System Repair, Protection, and Regenerative Potential in MS; or Correlates of Disease Activity and Progression in MS; or Biology and Measurements of MS Symptoms; or Mechanisms Contributing to or Associated with MS Etiology, Prodrome, Onset, and Disease
Course - Document – Funding Announcement: HT942524MSRPIIRA_GG
